LGALS3 and ductal breast carcinoma in situ: A Levene’s Test for Homogeneity of Variance was performed, indicating a statistically significant difference in variances between the samples from patients with invasive ductal carcinoma and the samples from patients with ductal carcinoma in situ for galectin-3 and -9.